Stock Earnings

Question 1

Beam Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Beam Therapeutics Incの総資産は$1,103で、純lossは$-376です。

Question 2

BEAMの主要な財務比率は何ですか？

Accepted Answer

Beam Therapeutics Incの流動比率は2.98、純利益率は-596.82、1株当たり売上高は$0.76です。

Question 3

Beam Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Beam Therapeutics Inc largest revenue segment is Genetic Medicines, at a revenue of 63,518,000 in the most earnings release.For geography, United States is the primary market for Beam Therapeutics Inc, at a revenue of 63,518,000.

Question 4

Beam Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Beam Therapeutics Incの純lossは$-376です。

Question 5

Beam Therapeutics Incに負債はありますか？

Accepted Answer

yes、Beam Therapeutics Incの負債は370です。

Question 6

Beam Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Beam Therapeutics Incの総発行済株式数は83.63株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	60	63	377	60	51	0
Revenue Growth (YoY)	-83%	-83%	528%	18%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	109	111	116	87	57	29
Research & Development	396	367	437	311	387	103
Operating Expenses	506	479	554	399	444	132
Other Non Operating Income (Expenses)	0	1	9	18	22	--
Pretax Income	-398	-376	-131	-260	-370	-194
Income Tax Expense	0	0	1	3	--	--
Net Income	-398	-376	-132	-289	-370	-195
Net Income Growth	178%	185%	-54%	-22%	90%	113.99%
Shares Outstanding (Diluted)	101.99	82.31	77.15	70.02	64.23	46.73
Shares Change (YoY)	24%	7%	10%	9%	37%	3%
EPS (Diluted)	-3.9	-4.57	-1.71	-4.13	-5.77	-4.19
EPS Growth	125%	166%	-57.99%	-28%	38%	108%
Free Cash Flow	-355	-356	-182	-26	-113	-112
Free Cash Flow Per Share	-3.48	-4.32	-2.35	-0.37	-1.75	-2.39
Gross Margin	--	--	--	--	--	--
Operating Margin	-741.66%	-658.73%	-46.68%	-563.33%	-768.62%	0%
Profit Margin	-663.33%	-596.82%	-35.01%	-481.66%	-725.49%	0%
Free Cash Flow Margin	-591.66%	-565.07%	-48.27%	-43.33%	-221.56%	0%
EBITDA	-424	-394	-156	-324	-385	-128
EBITDA Margin	-706.66%	-625.39%	-41.37%	-540%	-754.9%	0%
D&A For EBITDA	21	21	20	14	7	4
EBIT	-445	-415	-176	-338	-392	-132
EBIT Margin	-741.66%	-658.73%	-46.68%	-563.33%	-768.62%	0%
Effective Tax Rate	0%	0%	-0.76%	-1.15%	--	--

Beam Therapeutics Inc (BEAM) Price

BEAM Stock Price Chart

BEAM Income

Follow-Up Questions